Peptide affinity and concentration affect the sensitivity of M3- restricted CTLs induced in vitro

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3022-3028

  Byers, Derek E ^a   Lindahl, Kirsten Fischer ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033568203     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. + T cell pools. Eur. J. Immunol. 25:2127.
2. b-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158.
3. Tsai, V., S. Southwood, J. Sidney, K. Sakaguchi, Y. Kawakami, E. Appella, A. Sette, and E. Celis. 1997. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol. 158:1796.
4. Busch, D. H., and E. G. Pamer. 1998. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 160:4441.
5. Nair, S., J. S. Babu, R. G. Dunham, P. Kanda, R. L. Burke, and B. T. Rouse. 1993. Induction of primary, antiviral cytotoxic and proliferative responses with antigens administered via dendritic cells. J. Virol. 67:4062.
6. Stauss, H. J., H. Davies, E. Sadovnikova, B. Chain, N. Horowitz, and C. Sinclair 1992. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. Proc. Natl. Acad. Sci. USA 89:7871.
7. Ikeda-Moore, Y., H. Tomiyama, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. J. Immunol. 159:6242.
8. Rooney, C. M., C. A. Smith, C. Y. Ng, S. K. Loftin, J. W. Sixbey, Y. Gan, D. K. Srivastava, L. C. Bowman, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1998. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549.
9. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238.
10. Carbone, F. R., M. W. Moore, J. M. Sheil, and M. J. Bevan. 1988. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J. Exp. Med. 167:1767.
11. De Bruijn, M. L., T. N. Schumacher, J. D. Nieland, H. L. Ploegh, W. M. Kast, and C. J. Melief. 1991. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur. J. Immunol. 21:2963.
12. Wentworth, P. A., E. Celis, C. Crimi, S. Stitely, L. Hale, V. Tsai, H. M. Serra, M. F. Del Guercio, B. Livingston, and D. Alazard. 1995. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol. 32:603.
13. Byers, D. E., and K. Fischer Lindahl. 1998. H2-M3 presents a nonformylated viral epitope to CTLs generated in vitro. J. Immunol. 161:90.
14. Staerz, U. D., F. Zepp, R. Schmid, M. Hill, and J. Rothbard. 1989. Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide. Eur. J. Immunol. 19:2191.
15. Alexander-Miller, M. A., G. R. Leggatt, and J. A. Berzofsky. 1996. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93:4102.
16. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
17. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89.
18. Fischer Lindahl, K., D. E. Byers, V. M. Dabhi, R. Hovik, E. P. Jones, G. P. Smith, C. R. Wang, H. Xiao, and M. Yoshino. 1997. H2-M3, a full-service class Ib histocompatibility antigen. Annu. Rev. Immunol. 15:851.
19. Smith, G. P., V. M. Dabhi, E. G. Pamer, and K. Fischer Lindahl. 1994. Peptide presentation by the MHC class Ib molecule, H2-M3. Int. Immunol. 6:1917.
20. Gulden, P. H., P. Fischer III, M. E. Sherman, W. Wang, V. H. Engelhard, J. Shabanowitz, D. F. Hunt, and E. G. Pamer. 1996. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 5:73.
21. Lenz, L. L., B. Dere, and M. J. Bevan. 1996. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity 5:63.
22. Princiotta, M. F., L. L. Lenz, M. J. Bevan, and U. D. Staerz. 1998. H2-M3 restricted presentation of a Listeria-derived leader peptide. J. Exp. Med 187: 1711.
23. Pamer, E. G., M. J. Bevan, and K. Fischer Lindahl. 1993. Do nonclassical, class Ib MHC molecules present bacterial antigens to T cells? Trends Microbiol. 1:35.
24. Milligan, G. N., L. Flaherty, V. L. Braciale, and T. J. Braciale. 1991. Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes. J. Exp. Med. 174:133.
25. Dabhi, V. M., and K. Fischer Lindahl. 1995. MtDNA-encoded histocompatibility antigens. Methods Enzymol. 260:466.
26. Dabhi, V. M., R. Hovik, L. Van Kaer, and K. Fischer Lindahl. 1998. The alloreactive T cell response against the class Ib molecule H2-M3 is specific for high affinity peptides. J. Immunol. 161:5171.
27. Morse, H. C., R. Riblet, R. Asofsky, and M. Weigert. 1978. Plasmacytomas of the NZB mouse. J. Immunol. 121:1969.
28. Fischer Lindahl, K., and B. Hausmann. 1980. Expression of the I-E target antigen for T-cell killing requires two genes. Immunogenetics 11:571.
29. Wang, C-R., A. R. Castaño, P. A. Peterson, C. Slaughter, K. Fischer Lindahl, and J. Deisenhofer. 1995. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell 82:655.
30. Dabhi, V. M., and K. Fischer Lindahl. 1998. Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3. Eur. J. Immunol. 28: 3773.
31. Byers, D. E. 1999. The cytotoxic T lymphocyte response to a viral peptide presented by H2-M3. Doctoral dissertation. University of Texas Southwestern Graduate School, Dallas, TX.
32. Morse, M. C., G. Bleau, V. M. Dabhi, F. Hétu, E. A. Drobetsky, K. Fischer Lindahl, and C. Perreault. 1996. The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3. J. Immunol. 156:3301.
33. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565.
34. Kageyama, S., T. J. Tsomides, Y. Sykulev, and H. N. Eisen. 1995. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 154:567.
35. Alexander-Miller, M. A., G. R. Leggatt, A. Sarin, and J. A. Berzofsky. 1996. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 184:485.